Publications by authors named "Fei-Yu Shi"
Article Synopsis
- - This study compares the outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) in patients with gastric cancer, analyzing data from 3599 patients in China over a four-year period.
- - After matching patients for a fair comparison, both RG and LG showed similar 3-year disease-free survival (83.7% for RG vs. 83.1% for LG) and overall survival rates (85.2% for RG vs. 84.4% for LG) without significant differences in recurrence patterns.
- - RG had advantages such as less blood loss, lower conversion rates to open surgery, and shorter hospital stays, making it a safe alternative to LG with comparable oncological outcomes
Background: The aim of this multicentre cohort study was to compare the long-term oncological outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) for patients with gastric cancer.
Methods: Patients with gastric cancer who underwent radical gastrectomy by robotic or laparoscopic approaches from 1 March 2010 to 31 December 2018 at 10 high-volume centres in China were selected from institutional databases. Patients receiving RG were matched 1 : 1 by propensity score with patients undergoing LG.
The microbiome in a specific human organ has been well-studied, but few reports have investigated the multi-organ microbiome as a whole. Here, we aim to analyse the intra-individual inter-organ and intra-organ microbiome in deceased humans. We collected 1608 samples from 53 sites of 7 surface organs (oral cavity, esophagus, stomach, small intestine, appendix, large intestine and skin; n = 33 subjects) and performed microbiome profiling, including 16S full-length sequencing.
View Article and Find Full Text PDFObjective: A large-scale multicenter retrospective cohort study was conducted to compare the short- and long-term outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) for gastric cancer.
Summary Of Background Data: RG is being increasingly used worldwide, but data from large-scale multicenter studies on the short- and long-term oncologic outcomes of RG versus LG are limited. The potential benefits of RG compared with LG for gastric cancer remain controversial.
Background: MicroRNAs (miRNAs) play key roles in tumorigenesis and progression of gastric cancer (GC). miR-1269 has been reported to be upregulated in several cancers and plays a crucial role in carcinogenesis and cancer progression. However, the biological function of miR-1269 in human GC and its mechanism remain unclear and need to be further elucidated.
View Article and Find Full Text PDF